ANAVEX3-71 oral capsules

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Study of ANAVEX3-71 in Adults With SchizophreniaNCT06245213AVXLPhase 2Active not recruiting2025-06-30Estimated

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.